Gliclazide (Gliclazide)

Gliclazide: description, application and trade name

Gliclazide is an oral hypoglycemic drug that is widely used to treat non-insulin-dependent (type II) diabetes mellitus. This medicine belongs to the group of sulfonylureas, which help lower blood sugar levels by stimulating the release of insulin from the pancreas.

Gliclazide works by increasing the amount of insulin secreted by the pancreas and improving tissue sensitivity to insulin. This helps reduce blood sugar levels in patients with type II diabetes.

Gliclazide also has other beneficial properties, such as protecting pancreatic cells and blood vessel endothelium from damage caused by hyperglycemia. This may help prevent complications associated with diabetes.

The trade name of gliclazide is Diamicron. This medicine is available in various dosages, which can be individualized for each patient depending on the severity of the disease and other factors.

Gliclazide is usually taken once a day with food to help control blood sugar levels. However, the dosage may vary depending on the individual needs of the patient and the doctor's recommendations.

Overall, gliclazide is an effective and relatively safe medicine for the treatment of non-insulin-dependent (type II) diabetes mellitus. However, like all medicines, gliclazide may have side effects such as hypoglycemia (low blood sugar), nausea, vomiting and diarrhea. Therefore, it is always necessary to follow the doctor’s recommendations and not exceed the recommended dose of the medicine.

In conclusion, gliclazide (Diamicron) is an effective and widely used drug for the treatment of non-insulin-dependent diabetes mellitus. It can help control blood sugar levels and prevent the development of complications associated with this disease. However, you should always follow your doctor's recommendations and not exceed the recommended dose of the medicine to avoid possible side effects.

Gliclazide is an oral hypoglycemic drug that contains a sulfonylurea; used to treat non-insulin-dependent (type II) diabetes mellitus. Trade name: Diamicron.

Gliclazide belongs to the group of oral antidiabetic drugs - sulfonylurea derivatives. It stimulates the secretion of insulin by pancreatic β-cells, which leads to a decrease in blood glucose levels. Gliclazide is used for type 2 diabetes, when the body does not respond properly to the insulin produced. The drug increases tissue sensitivity to insulin and stimulates insulin production by β-cells. This leads to a decrease in blood sugar levels.

Gliclazide is available in tablets under trade names such as Diamicron, Glucovance, Diabeton, etc. The usual daily dose is 80-320 mg in 1 or 2 doses. The dose is selected individually depending on the level of glucose in the blood. Treatment with gliclazide is usually carried out in combination with diet and exercise.

Gliclazide is one of the most common drugs used to treat diabetes mellitus (type 2 diabetes) due to its effect on the pancreas. But it is important to understand that gliclazide is not a panacea and may not be suitable for all patients.

First of all, gliclazide is preceded